Bortezomib cancer drug molecule

Bortezomib cancer drug molecule

A624/0455 Rights Managed

Request low-res file

530 pixels on longest edge, unwatermarked

Request/Download high-res file

Uncompressed file size: 70.8MB

Downloadable file size: 972.7KB

Price image Pricing

Please login to use the price calculator


Caption: Bortezomib cancer drug. Computer model of a molecule of the cancer drug bortezomib. This drug, which is marketed as Velcade, is used to treat a type of cancer known as myeloma. Myeloma is a cancer of blood plasma cells found in bone marrow, and can spread to cause multiple cancers in different areas of the body. Bortezomib belongs to a class of drugs, called proteasome inhibitors, that help to prevent the cancers that result from protein breakdowns. Approval was granted in the USA in 2003 and in Europe in 2004. The molecule's chemical formula is C19.H25.B.N4.O4. The atoms are shown as colour-coded spheres in this space-filled model: carbon (grey), hydrogen (yellow), boron (green), nitrogen (dark blue) and oxygen (red).

Release details: Model release not required. Property release not required.

Keywords: anti-cancer, artwork, biochemical, biochemistry, blood cells, bone marrow, botezomib, cancer, chemical, chemistry, chemotherapy, compound, compounds, computer artwork, computer graphic, drug, filled, illustration, medical, medicine, molecular, molecular model, molecule, molecules, myeloma, oncology, one, pharmaceutic, pharmaceutics, pharmacological, pharmacology, plasma, proteasome inhibitor, single, space fill, space-fill, spheres, structural, structure, treatment, velcade

Licence fees: A licence fee will be charged for any media (low or high resolution) used in your project.